48,833
edits
Line 3: | Line 3: | ||
==General== | ==General== | ||
*Predominantly in women.<ref name=pmid24389164>{{Cite journal | last1 = Mehra | first1 = R. | last2 = Vats | first2 = P. | last3 = Kalyana-Sundaram | first3 = S. | last4 = Udager | first4 = AM. | last5 = Roh | first5 = M. | last6 = Alva | first6 = A. | last7 = Pan | first7 = J. | last8 = Lonigro | first8 = RJ. | last9 = Siddiqui | first9 = J. | title = Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing. | journal = Am J Pathol | volume = 184 | issue = 3 | pages = 584-91 | month = Mar | year = 2014 | doi = 10.1016/j.ajpath.2013.11.023 | PMID = 24389164 }}</ref> | *Predominantly in women.<ref name=pmid24389164>{{Cite journal | last1 = Mehra | first1 = R. | last2 = Vats | first2 = P. | last3 = Kalyana-Sundaram | first3 = S. | last4 = Udager | first4 = AM. | last5 = Roh | first5 = M. | last6 = Alva | first6 = A. | last7 = Pan | first7 = J. | last8 = Lonigro | first8 = RJ. | last9 = Siddiqui | first9 = J. | title = Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing. | journal = Am J Pathol | volume = 184 | issue = 3 | pages = 584-91 | month = Mar | year = 2014 | doi = 10.1016/j.ajpath.2013.11.023 | PMID = 24389164 }}</ref> | ||
*May be of renal origin.<ref name=pmid23307189/> | |||
==Microscopic== | ==Microscopic== | ||
Line 13: | Line 14: | ||
DDx: | DDx: | ||
*[[Nephrogenic adenoma]] - also has hobnailing. | *[[Nephrogenic adenoma]]<ref name=pmid23307189/> - also has hobnailing. | ||
*[[Clear cell | *[[Clear cell renal cell carcinoma]]. | ||
*[[Clear cell adenocarcinoma]] of the gynecologic tract. | |||
* | *Other [[clear cell tumours]]. | ||
===Images=== | ===Images=== | ||
Line 24: | Line 24: | ||
==IHC== | ==IHC== | ||
Features: | Features:<ref name=pmid23307189/> | ||
*PAX8 +ve. | *PAX8 +ve/-ve (2 +ve in 4 cases. | ||
*CK7 +ve. | *CK7 +ve/-ve (2 +ve in 4 cases). | ||
*Vimentin +ve (3 +ve in 4 cases). | |||
*CK20 -ve/+ve (1 +ve in 4 cases). | |||
Others: | Others:<ref name=pmid23307189/> | ||
*ER -ve. | *ER -ve. | ||
*p63 -ve. | *p63 -ve. | ||
*[[PSA]] -ve. | |||
*p16 -ve. | |||
==See also== | ==See also== |
edits